Rising Incidence of Type 1 Diabetes Is Associated With Altered Immunophenotype at Diagnosis
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The incidence of type 1 diabetes has increased rapidly over recent decades, particularly in young children. We aimed to determine whether this rise was associated with changes in patterns of humoral islet autoimmunity at diagnosis. Autoantibodies to insulin (IAA), GAD (GADA), islet antigen-2 (IA-2A), and zinc transporter 8 (ZnT8A) were measured by radioimmunoassay in sera collected from children and young adults with newly diagnosed type 1 diabetes between 1985 and 2002. The influence of date of diagnosis on prevalence and level of autoantibodies was investigated by logistic regression with adjustment for age and HLA class II genetic risk. Prevalence of IA-2A and ZnT8A increased significantly over the period studied, and this was mirrored by raised levels of IA-2A, ZnT8A, and IA-2β autoantibodies (IA-2βA). IAA and GADA prevalence and levels did not change. Increases in IA-2A, ZnT8A, and IA-2βA at diagnosis during a period of rising incidence suggest that the process leading to type 1 diabetes is now characterized by a more intense humoral autoimmune response. Understanding how changes in environment or lifestyle alter the humoral autoimmune response to islet antigens should help explain why the incidence of type 1 diabetes is increasing and may suggest new strategies for preventing disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The prevalence of IA‐2βA and autoantibodies recognizing the protein tyrosine phosphatase region of IA‐2 (PTPA) also increased during this time‐span.”
From Islet autoantibody profiles associated with higher diabetes risk in Lithuanian compared with English schoolchildren (2020) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The thresholds used to assign antibody positivity for IA‐2‐related antibodies have been previously published applied to newly diagnosed children [8]; nevertheless, they were set using different populations of healthy individuals.”
From Islet autoantibody profiles associated with higher diabetes risk in Lithuanian compared with English schoolchildren (2020) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“We previously investigated autoantibody prevalence at diagnosis in patients from the same geographical region as the English schoolchildren during a 17‐year time‐span, when type 1 diabetes incidence rose and prevalence of ZnT8A and IA‐2A increased [ 8 ].”
From Islet autoantibody profiles associated with higher diabetes risk in Lithuanian compared with English schoolchildren (2020) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterson, C. C., Dahlquist, G. G., Gyürüs, E., Green, A., & Soltész, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60568-7 · Cited by 1,854 · cited 1×
“The incidence of type 1 diabetes is rising by 3–4% per year across Europe, North America, and Australia, with the greatest increase in children diagnosed at ,5 years of age (1,2).”
BackgroundThe cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
Wenzlau, J. M., Juhl, K., Yu, L., Moua, O., Sarkar, S. A., Gottlieb, P., Rewers, M., Eisenbarth, G. S., Jensen, J., Davidson, H. W., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705894104 · Cited by 1,014
The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes
Wilkin, T. J. (2001) · Diabetologia · doi:10.1007/s001250100548 · Cited by 623 · cited 1×
“Lifestyle changes could therefore play a role in stimulating autoantibody production through increased islet autoantigen expression (20,21), but there are currently no data directly supporting this association (22).”
BackgroundBingley, P. J., Bonifacio, E., Williams, A. J. K., Genovese, S., Bottazzo, G. F., & Gale, E. A. M. (1997) · Diabetes · doi:10.2337/diab.46.11.1701 · Cited by 461
Self-citationPrediction and Pathogenesis in Type 1 Diabetes
Ziegler, A.-G., & Nepom, G. T. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.018 · Cited by 346 · cited 3×
“The antibodies that increased over the study period, IA-2A and ZnT8A, usually appear after GADA and IAA (6).”
BackgroundGillespie, K. M., Bain, S. C., Barnett, A. H., Bingley, P. J., Christie, M. R., Gill, G. V., & Gale, E. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17357-1 · Cited by 304
Self-citationBonifacio, E., Yu, L., Williams, A. K., Eisenbarth, G. S., Bingley, P. J., Marcovina, S. M., Adler, K., Ziegler, A. G., Mueller, P. W., Schatz, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0293 · Cited by 291 · cited 1×
“and IA-2A in DK units/mL (14) derived from standard curves, with extrapo-”
MethodSelf-citationGardner, S. G., Bingley, P. J., Sawtell, P. A., Weeks, S., & Gale, E. A. (1997) · BMJ · doi:10.1136/bmj.315.7110.713 · Cited by 242
Self-citationLambert, A. P., Gillespie, K. M., Thomson, G., Cordell, H. J., Todd, J. A., Gale, E. A. M., & Bingley, P. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032084 · Cited by 241
Self-citationAntiislet autoantibodies usually develop sequentially rather than simultaneously
Yu, L. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.12.4264 · Cited by 214 · cited 2×
“As islet autoimmunity evolves, there is typically spreading of reactivity to different target autoantigens and epitopes (5).”
BackgroundWenzlau, J. M., Liu, Y., Yu, L., Moua, O., Fowler, K. T., Rangasamy, S., Walters, J., Eisenbarth, G. S., Davidson, H. W., & Hutton, J. C. (2008) · Diabetes · doi:10.2337/db08-0522 · Cited by 205 · cited 2×
“recognizing either arginine (ZnT8RA) or tryptophan (ZnT8WA) at position 325 (15).”
BackgroundIncreasing levels of excess weight among children in England
Lobstein, T. J., James, W. P. T., & Cole, T. J. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802324 · Cited by 197 · cited 1×
“children has increased during this period (19).”
IA-2 autoantibodies predict impending Type I diabetes in siblings of patients
Decochez, K., Leeuw, I. D., Keymeulen, B., Mathieu, C., Rottiers, R., Weets, I., Vandemeulebroucke, E., Truyen, I., Kaufman, L., Schuit, F. C., et al. (2002) · Diabetologia · doi:10.1007/s00125-002-0949-8 · Cited by 106 · cited 1×
“IAA are generally the first autoantibodies to be detected in infancy, followed by GADA (6), while IA-2A and ZnT8A tend to appear later and may mark a critical turning point in the process leading to b-cell destruction (5,7,8).”
BackgroundSpring harvest? Reflections on the rise of type 1 diabetes
Gale, E. A. M. (2005) · Diabetologia · doi:10.1007/s00125-005-0028-z · Cited by 101 · cited 1×
“The reason for the rise in incidence remains obscure but has been attributed to changes in environment and/or lifestyle (4).”
BackgroundNaserke, H. E., Ziegler, A.-G., Lampasona, V., & Bonifacio, E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6963 · Cited by 98 · cited 2×
“Spreading of autoreactivity within antigens shows a distinct pattern; autoantibodies to epitopes in the juxtamembrane region of IA-2 (JMA) often arise early and develop independently of responses to protein tyrosine phosphatase epitopes of IA-2 (9), while antibodies to IA-2b (IA-2bA) may signal advanced autoimmunity a…”
BackgroundIncidence of insulin dependent diabetes in England: a study in the Oxford region, 1985-6.
Bingley, P. J., & Gale, E. A. (1989) · BMJ · doi:10.1136/bmj.298.6673.558 · Cited by 87
Self-citationZiegler, A.-G., Pflueger, M., Winkler, C., Achenbach, P., Akolkar, B., Krischer, J. P., & Bonifacio, E. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.02.004 · Cited by 81 · cited 1×
“from islet autoantibody positivity to diabetes was faster in young children born in 2004–2010 than in those born in 1989–2000, despite a similar frequency of islet autoantibodies (25).”
BackgroundWenzlau, J. M., Walter, M., Gardner, T. J., Frisch, L. M., Yu, L., Eisenbarth, G. S., Ziegler, A.-G., Davidson, H. W., & Hutton, J. C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0169 · Cited by 74 · cited 1×
“Another possibility could be that recent patients were diagnosed earlier in disease pathogenesis, with greater b-cell mass remaining to stimulate autoantibody production, particularly of ZnT8A, which drop rapidly after diagnosis (23).”
BackgroundBuschard, K., Brogren, C., Röpke, C., & Rygaard, J. (1988) · Apmis · doi:10.1111/j.1699-0463.1988.tb05313.x · Cited by 60 · cited 1×
“Lifestyle changes could therefore play a role in stimulating autoantibody production through increased islet autoantigen expression (20,21), but there are currently no data directly supporting this association (22).”
BackgroundLipponen, K., Gombos, Z., Kiviniemi, M., Siljander, H., Lempainen, J., Hermann, R., Veijola, R., Simell, O., Knip, M., & Ilonen, J. (2010) · Diabetes · doi:10.2337/db10-0167 · Cited by 54 · cited 1×
“What might have caused these changes in islet autoantibodies? We adjusted for age at diagnosis and HLA Class II genotype in our analysis; therefore, changes in these factors do not explain our findings, although we have not examined potential changes in the frequency of non-HLA genes (18).”
Autoantibodies to IA-2β improve diabetes risk assessment in high-risk relatives
Achenbach, P., Bonifacio, E. E., Williams, A. J. K., Ziegler, A., Gale, E. A. M., Bingley, P. J., & ENDIT Group (2008) · Diabetologia · doi:10.1007/s00125-007-0912-9 · Cited by 48
Self-citationWilliams, A. J. K., Norcross, A. J., Dix, R. J., Gillespie, K. M., Gale, E. A. M., & Bingley, P. J. (2003) · Diabetologia · doi:10.1007/s00125-003-1197-2 · Cited by 44 · cited 2×
“We used logistic regression models to adjust for factors previously shown to be associated with islet autoantibodies in the BOX study (sex, age at diagnosis, and DR-DQ genotype) (12,17).”
BackgroundMethodSelf-citationWilliams, A. J. K., Aitken, R. J., Chandler, M. A.-M., Gillespie, K. M., Lampasona, V., & Bingley, P. J. (2008) · Diabetologia · doi:10.1007/s00125-008-1047-3 · Cited by 34 · cited 3×
“We used logistic regression models to adjust for factors previously shown to be associated with islet autoantibodies in the BOX study (sex, age at diagnosis, and DR-DQ genotype) (12,17).”
BackgroundMethodSelf-citationWinkler, C., Marienfeld, S., Zwilling, M., Bonifacio, E. E., & Ziegler, A. (2009) · Diabetologia · doi:10.1007/s00125-009-1461-1 · Cited by 31 · cited 1×
“Lifestyle changes could therefore play a role in stimulating autoantibody production through increased islet autoantigen expression (20,21), but there are currently no data directly supporting this association (22).”
BackgroundWong, N., Wang, S. S., Lamoureux, E. L., Wong, T. Y., Tikellis, G., Harper, A., & Wang, J. J. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02614.x · Cited by 16
Research works printed but not linked: 1
- Ali, 2009, Diabetic ketoacidosis at diagnosis has not declined in children over the last 20 years: data from the Bart’s-Oxford Study, Diabet Med, 26, 34
Cited by
Athyros, V. G., Doumas, M., Imprialos, K. P., Stavropoulos, K., Georgianou, E., Katsimardou, A., & Karagiannis, A. (2018) · Hormones · doi:10.1007/s42000-018-0014-8 · Cited by 367
Environmental and genetic contributions to diabetes
Tremblay, J., & Hamet, P. (2019) · Metabolism · doi:10.1016/j.metabol.2019.153952 · Cited by 163
Bravis, V., Kaur, A., Walkey, H. C., Godsland, I. F., Misra, S., Bingley, P. J., Williams, A. J. K., Dunger, D. B., Dayan, C. M., Peakman, M., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020904 · Cited by 91
Self-citationAdvances in the cellular immunological pathogenesis of type 1 diabetes
Li, M., Song, L., & Qin, X. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12270 · Cited by 92
“Autoantibodies directed against islet autoantigens such as insulin, glutamic acid decarboxylase 65 (GAD 65), islet antigen-2 (IA-2) and Zinc transporter 8 (ZnT8) have been demonstrated to be markers of the islet autoimmunity that precede clinical onset of T1D [9, 10] (Fig.”
BackgroundVehik, K., Bonifacio, E., Lernmark, Å., Yu, L., Williams, A., Schatz, D., Rewers, M., She, J.-X., Toppari, J., Hagopian, W., et al. (2020) · Diabetes Care · doi:10.2337/dc19-2547 · Cited by 87
Self-citation
Metadata
- Authors
- Long, A. E., Gillespie, K. M., Rokni, S., Bingley, P. J., & Williams, A. J. K.
- Affiliations
- University of Bristol (GB)
- Corresponding author
- Williams, Alistair J.K.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2012-02-13
- Volume
- 61
- Issue
- 3
- Pages
- 683-686
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3282823
- OpenAlex
- W2098405716
- Cited by
- 60
- References
- 25
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 7 · 2022: 3 · 2021: 4 · 2020: 6 · 2019: 5 · 2018: 4 · 2017: 7 · 2016: 4 · 2015: 4 · 2014: 4 · 2013: 2 · 2012: 7
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- Explore Bristol Research (submittedVersion)
- Funders
- Wellcome Trust
- University of Bristol
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- type 1 diabetes, incidence trends, humoral autoimmunity, islet autoantibodies, IA-2 autoantibodies, zinc transporter 8 autoantibodies, insulin autoantibodies, glutamic acid decarboxylase antibodies, immunophenotype, children and young adults, HLA class II, disease prevention
- MeSH terms
- Zinc Transporter 8, Adolescent, Adult, Autoantibodies, Child, Child, Preschool, Diabetes Mellitus, Type 1, Female, Humans, Infant, Male, Logistic Models, Immunophenotyping, Cation Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.